Indian Regulators Warn Companies Against “Unethical Promotion” Of Drugs To Doctors
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - India's drug price regulatory body, the National Pharmaceutical Pricing Authority, has come down heavily on perpetrators of "unethical promotion of drugs" to medical practitioners, adding that such moves push up drug prices, making them unaffordable to the masses